Abstract | BACKGROUND: METHODS: RESULTS:
Transforming growth factor-beta1 was significantly elevated in hypertensive obese patients (n = 46) as compared with TGF-beta1 levels of hypertensive patients with normal BMI (n = 29) (8. 9 +/- 3 ng/mL v 4.4 +/- 2; P < .001). The circulating levels of TGF-beta1 were associated with BMI and leptin levels in an univariate analysis (r = 0.59, P < .0001; r = 0.62, P < .0001, respectively) and these associations were still present after stepwise multivariate analysis. Weight loss of 10% produced a parallel decrease in TGF-beta1 (from 8.9 +/- 3 ng/mL to 5.3 +/- 2.8 ng/mL; P < .01) and leptin levels (from 30 +/- 24 ng/mL to 17 +/- 14; P < .05). In vitro experiments showed that leptin is able to induce a dose-dependent increase in TGF-beta1 production and mRNA expression in human monocyte cultures. CONCLUSIONS: Our data indicate that TGF-beta1 levels are positively associated with BMI and leptin levels in hypertensive patients and suggest that adipose tissue may be an important determinant of TGF-beta1 levels possibly by a leptin-dependent pathway.
|
Authors | Ettore Porreca, Concetta Di Febbo, Ester Vitacolonna, Giovanna Baccante, Augusto Di Castelnuovo, Antonio Angelini, Francesca Febo, Marcello Di Nisio, Franco Cuccurullo |
Journal | American journal of hypertension
(Am J Hypertens)
Vol. 15
Issue 9
Pg. 759-65
(Sep 2002)
ISSN: 0895-7061 [Print] United States |
PMID | 12219869
(Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Leptin
- RNA, Messenger
- Transforming Growth Factor beta
|
Topics |
- Adult
- Blood Pressure
(physiology)
- Body Mass Index
- Female
- Gene Expression
(genetics)
- Humans
- Hypertension
(blood, complications, physiopathology)
- In Vitro Techniques
- Leptin
(blood)
- Male
- Middle Aged
- Obesity
(blood, complications, physiopathology)
- RNA, Messenger
(genetics)
- Regression Analysis
- Transforming Growth Factor beta
(blood, genetics)
- Weight Loss
(physiology)
|